Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer

American Journal of Pathology

Volumn 150, Issue 5, 1997, Pages 1827-1833

  Huang, Aihua ^a   Leygue, Etienne R ^a   Snell, Linda ^a   Murphy, Leigh C ^a   Watson, Peter H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CANCER; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE;

EID: 0030999875     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Benner SE, Clark GM, McGuire WL: Steroid receptors, cellular kinetics, and lymph node status as prognostic factors in breast cancer. Am J Med Sci 1988, 296: 59-66
2. Thorpe SM, Rose C, Rasmussen BB, Mouridsen HT, Keiding N: Prognostic value of steroid hormone receptor: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res 1987, 47:6126-6133
3. Snead DRJ, Bell JA, Dixon AR, Nicholson RI, Elston CW, Blamey RW, Ellis IO: Methodology of Immunohistological detection of estrogen receptor in human breast carcinoma In formalin-fixed, paraffin-embedded tissue: a comparison with frozen section methodology, Histopathology 1993, 23:233-238
4. Jotti GS, Johnston SRD Salter J, Detre S, Dowsett M: Comparison of new Immunohistochemical assay for estrogen receptor In paraffin wax embedded breast carcinoma tissue with quantitative enzyme Immunoassay, J Clin Pathol 1994, 47:900-905
5. Huang A, Pettigrew NM, Watson PH: Immunohistochemical assay for estrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody. J Pathol 1996, 180:223-227
6. Sluyser M: Mutation In the estrogen receptor gene, Hum Mutat 1995, 6:97-103
7. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL: Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991, 51:105-109
8. Dotzlaw H, Alkhalaf M, Murphy LC: Characterization of estrogen receptor variant mRNAs from human breast cancers, Mol Endocrinol 1992, 6:773-785
9. Fuqua SAW, Fitzgerald SO, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL: Inhibition of estrogen receptor activity by a naturally occurring variant in human breast tumors. Cancer Res 1992, 52:483-486
10. Pfeffer U, Fecarotta E, Castagnetta E, Vidall G: Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res 1993, 53:741-743
11. Sluyser M: Role of estrogen receptor variants In the development of hormone resistance In breast cancer. Clin Biochem 1992, 25:407-414
12. Madsen MW, Reiter BE, Lykkesfeldt AE: Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TamR-1 compared to the parental MCF-7 cell line. Mol Cell Endocrinol 1995, 109:197-207
13. Leygue E, Watson PH, Murphy LC: Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 1996, 88:284-290
14. Murphy LC, Wang M, Coutt A, Dotzlaw H: Novel mutations in the estrogen receptor messenger RNA in human breast cancer. J Clin Endocrinol Metab 1996, 181:1420-1427
15. Leygue E, Huang A, Murphy LC, Watson PH: Preva- lence of estrogen receptor variant mRNAs in human breast cancer. Cancer Res 1996, 56:4324-4327
16. Leygue E, Murphy LC, Kuttenn F, Watson PH: Triple primer polymerase chain reaction, a new way to quantify truncated mRNA expression, Am J Pathol 1996, 148:1097-1103
17. Watson P, Snell L, Parisien M: The role of a tumor bank in translational research. Can Med Assoc J 1996, 155: 281-283
18. Miller T, Snell L, Watson P: Microdissection/RT-PCR analysis of gene expression. Biotechniques 1996, 21: 38-44
19. McGuire WL, Chamness G, Fuqua SAW: Estrogen receptor variants in human breast cancer. Mol Endocrinol 1991, 5:1571-1577
20. Alberts SR, Ingle JN, Roche PR, Cha SS, Wold LE, Farr GH, Krook JE, Wieland HS: Comparison of estrogen receptor determinations by a biochemical ligand binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials. Cancer 1996, 78:764-772
21. Pertschuk LP, Feldman JG, Kim YD, Braithwaite L, Schneider F, Braverman AS, Axiotis C: Estrogen recep- tor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol-based ligand-binding assays. Cancer 1996, 77:2514-2519
22. Taylor CR: Paraffin section immunocytochemistry for estrogen receptor. Cancer 1996, 77:2419-2422
23. Allred DC: Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer. Am J Clin Pathol 1993, 99:1-3
24. Murphy LC, Hilsenbeck SG, Dotzlaw H, Fuqua SAW: Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. Clin Cancer Res 1995, 1:155-159
25. Castles CG, Fuqua SAW, Klotz DM, Hill SM: Expression of a constitutively active estrogen receptor variant in the estrogen receptor negative BT-20 human breast cancer cell line. Cancer Res 1993, 53:5934-5939
26. Pink JJ, Wu SQ, Wolf DM, Bilimoria MM, Jordan VC: A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7, Nucleic Acids Res 1996, 24:962-969